Geselecteerde datamodellen

U moet ingelogd zijn om meerdere datamodellen te selecteren en die te downloaden of te analyseren.

112 Zoekresultaten.
Relevantie Beoordeling Nieuwe eerst Oude eerst

Eligibility Solid Tumors NCT00553189

- 30-10-18 - 1 Formulier, 2 Itemgroepen, 19 Data-elementen, 1 Taal
Itemgroepen: Criteria, Exclusion Criteria
Safety Study of ABT-888 Plus Topotecan Hydrochloride to Treat Patients With Solid Tumors and Lymphomas; ODM derived from: https://clinicaltrials.gov/show/NCT00553189

Eligibility Solid Tumors and Lymphomas NCT00457574

- 29-10-18 - 1 Formulier, 2 Itemgroepen, 10 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Safety and Efficacy of GMX1777 in the Treatment of Refractory Solid Tumors or Lymphomas; ODM derived from: https://clinicaltrials.gov/show/NCT00457574

Eligibility Non-gastric Marginal Zone Lymphoma NCT00377195

- 16-07-18 - 1 Formulier, 2 Itemgroepen, 15 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Involved Field Radiotherapy for Non-gastric Marginal Zone Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00377195

Eligibility MALT LYMPHOMA NCT01015248

- 14-06-18 - 1 Formulier, 2 Itemgroepen, 28 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Trial of Bendamustine And Rituximab for Patients With Previously Untreated Extranodal Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01015248

Eligibility Lymphoma, Small Lymphocytic NCT00636155

- 05-06-18 - 1 Formulier, 2 Itemgroepen, 17 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
EL625 in Persistent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00636155

Eligibility Lymphoma, High-grade NCT00554164

- 03-06-18 - 1 Formulier, 2 Itemgroepen, 14 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Positron Emission Tomography Guided Therapy of Aggressive Non-Hodgkin's Lymphomas; ODM derived from: https://clinicaltrials.gov/show/NCT00554164

Eligibility Lymphoma NCT01362972

- 03-06-18 - 1 Formulier, 2 Itemgroepen, 11 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry on a Cohort of Patients Receiving Plerixafor; ODM derived from: https://clinicaltrials.gov/show/NCT01362972

Eligibility Lymphoma NCT01144754

- 03-06-18 - 1 Formulier, 1 Itemgroep, 16 Data-elementen, 1 Taal
Itemgroep: Inclusion Criteria
Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT; ODM derived from: https://clinicaltrials.gov/show/NCT01144754

Eligibility Lymphoma NCT00967044

- 03-06-18 - 1 Formulier, 2 Itemgroepen, 36 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Panobinostat (LBH589) Plus Everolimus (RAD001) in Patients With Relapsed and Refractory Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00967044

Eligibility Lymphoma NCT00893477

- 02-06-18 - 1 Formulier, 1 Itemgroep, 20 Data-elementen, 1 Taal
Itemgroep: Criteria
GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00893477

Eligibility Lymphoma NCT00878254

- 02-06-18 - 1 Formulier, 1 Itemgroep, 21 Data-elementen, 1 Taal
Itemgroep: Criteria
Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00878254

Eligibility Lymphoma NCT00875056

- 02-06-18 - 1 Formulier, 2 Itemgroepen, 11 Data-elementen, 1 Taal
Itemgroepen: Inclusion Criteria, Exclusion Criteria
Study of Vorinostat (MK0683) With Follicular Lymphoma (FL), Other Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL) or Mantle Cell Lymphoma (MCL) Patients (MK-0683-103); ODM derived from: https://clinicaltrials.gov/show/NCT00875056

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial